Nitroxoline-O-protected derivatives inhibit MetAP2 and activate ATF4 through mTORC1 to inhibit cancer cell growth.
- DOI
- 10.1016/j.bmcl.2026.130642
- Published
- 2026 Aug
- Container
- Bioorganic & medicinal chemistry letters
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bmcl.2026.130642,
title = {Nitroxoline-O-protected derivatives inhibit MetAP2 and activate ATF4 through mTORC1 to inhibit cancer cell growth.},
author = {Williams MJ and Ronayne CT and Schumacher TJ and Johnson KM and Wittmer MD and Johnson JL and Anderson GW and Mereddy VR},
year = {2026},
journal = {Bioorganic \& medicinal chemistry letters},
doi = {10.1016/j.bmcl.2026.130642},
url = {https://doi.org/10.1016/j.bmcl.2026.130642}
}RIS
TY - JOUR TI - Nitroxoline-O-protected derivatives inhibit MetAP2 and activate ATF4 through mTORC1 to inhibit cancer cell growth. AU - Williams MJ AU - Ronayne CT AU - Schumacher TJ AU - Johnson KM AU - Wittmer MD AU - Johnson JL AU - Anderson GW AU - Mereddy VR PY - 2026 JO - Bioorganic & medicinal chemistry letters DO - 10.1016/j.bmcl.2026.130642 UR - https://doi.org/10.1016/j.bmcl.2026.130642 ER -
APA
MJ, W., CT, R., TJ, S., KM, J., MD, W., JL, J., GW, A., & VR, M. (2026). Nitroxoline-O-protected derivatives inhibit MetAP2 and activate ATF4 through mTORC1 to inhibit cancer cell growth.. Bioorganic & medicinal chemistry letters. https://doi.org/10.1016/j.bmcl.2026.130642
Source records
- pubmed · retrieved 2026-09-26T15:50:59.614Z